Paola Montal-Vidal

Barcelona, CT 08907, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Health-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case-Control Analysis of Physical and Mental Health Domains.

Health-Related Quality of Life in Older Adults with Rheumatoid Arthritis: A Sex-Specific Case-Control Analysis of Physical and Mental Health Domains.

Journal: Journal of clinical medicine
Published: January 26, 2026

Nutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index.

Nutritional Risk in Older Adults with Rheumatoid Arthritis: Sex-Specific Patterns and Clinical Implications of the Prognostic Nutritional Index.

Journal: Nutrients
Published: January 21, 2026

SARC-F as a Screening Tool in Rheumatoid Arthritis: Real-World Burden of Sarcopenia Risk, Sex Differences, and Clinical Correlates.

SARC-F as a Screening Tool in Rheumatoid Arthritis: Real-World Burden of Sarcopenia Risk, Sex Differences, and Clinical Correlates.

Journal: Journal of clinical medicine
Published: October 01, 2025

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry.

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry.

Journal: Lupus science & medicine
Published: September 25, 2025

Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry.

Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry.

Journal: Rheumatology (Oxford, England)
Published: September 15, 2025

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.

Journal: Rheumatology (Oxford, England)
Published: August 27, 2025

Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.

Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.

Journal: Rheumatology (Oxford, England)
Published: August 27, 2025

Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis.

Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis.

Journal: Arthritis research & therapy
Published: June 21, 2025

Malnutrition and Osteosarcopenia in Elderly Women with Rheumatoid Arthritis: A Dual Clinical Perspective.

Malnutrition and Osteosarcopenia in Elderly Women with Rheumatoid Arthritis: A Dual Clinical Perspective.

Journal: Nutrients
Published: May 21, 2025

Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications.

Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications.

Journal: Seminars in arthritis and rheumatism
Published: May 21, 2025

Fatigue and associated factors in men with rheumatoid arthritis: a case-control study using the FACIT-F scale.

Fatigue and associated factors in men with rheumatoid arthritis: a case-control study using the FACIT-F scale.

Journal: Frontiers in medicine
Published: January 03, 2025

Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis.

Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis.

Journal: Lupus science & medicine
Published: September 02, 2024
Showing 1-12 of 24

Last Updated: 09/26/2026